相关实验视频

Updated: Jul 11, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

27.1K

对于异调的外围T细胞淋巴瘤,用布伦图西马布维多丁重新治疗

Gen Hasegawa1, Noriharu Nakagawa1, Yoshimichi Ueda2

  • 1Department of Hematology, Keiju Medical Center, Nanao, Ishikawa, Japan.

Leukemia research reports
|February 3, 2025
PubMed
概括

布伦图西马布维多丁 (BV) 对CD30阳性外围T细胞淋巴瘤 (PTCL) 有效. 一名患有PTCL-NOS的患者,在BV-CHP治疗后出现,对BV单一治疗的再治疗做出了反应,这表明即使具有不同的表型,它的效用也是如此.

关键词:
布伦图西马布 (Brentuximab) 是一种可见的药物.不同的现象型不同.周围T细胞淋巴瘤再处理是重新处理.

更多相关视频

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.4K
Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.3K

相关概念视频

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...